Article

Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma

2023-10-19

Abstract excerpt

Glioblastoma (GBM) is a representative malignant brain tumor characterized by a dismal prognosis, with survival rates of less than 2 years and high recurrence rates. Despite surgical resection and several alternative treatments, GBM remains a refractory disease due to its aggressive invasiveness and resistance to anticancer therapy. In this report, we explore the role of fibronectin type III domain containing 3B (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 572d5a26-4517-5089-b5ba-f988ef470243
DOI: 10.20944/preprints202310.1264.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for GlioblastomaDOI 10.20944/preprints202310.1264.v1Read

FNDC3B is a Potential Prognostic Biomarker and Correlated With Immune Infiltrates in GliomaSemantic proximity Read

Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axisSemantic proximity Read

BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitatsSemantic proximity Read

Glioblastoma: An Update in Pathology, Molecular Mechanisms and BiomarkersSemantic proximity Read

Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.Semantic proximity Read

Identification of Potential Key Genes Associated with the Pathogenesis and Prognosis of Glioblastoma Based on Integrated Bioinformatics AnalysisSemantic proximity Read

DNA Methylation-based Diagnostic and Prognostic Biomarkers for GlioblastomaSemantic proximity Read

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma MultiformeSemantic proximity Read

Genomic profiling of cancerous patients identifies FPR2 as an alternative immunotherapeutic target in glioblastoma multiformeSemantic proximity Read

Elucidating the Predominant Role of AEBP1 in Different Types of Cancers with a Focus on Glioblastoma Progression – A ReviewSemantic proximity Read

Identification of novel genes associated with diagnosis and prognosis in glioblastomaSemantic proximity Read

RBM8A Promotes Glioblastoma Growth and Invasion Through the Notch/STAT3 PathwaySemantic proximity Read